M
Magenta Medical
Magenta Medical has developed a temporary venous catheter-based therapy
About Magenta Medical
Magenta Medical develops advanced medical devices focused on providing temporary support for patients with severe heart conditions. The company specializes in two main products: the percutaneous Left Ventricular Assist Device (pLVAD) and the Transcatheter Renal Venous Decongestion System. The pLVAD is a next-generation, low-profile arterial pump designed to offer temporary support for patients undergoing high-risk coronary interventions and those suffering from cardiogenic shock. The Transcatheter Renal Venous Decongestion System is a venous pump aimed at treating hospitalized patients with acutely decompensated heart failure by reducing renal venous pressure and decompressing the kidneys.
Read full description
Magenta Medical primarily serves hospitals and healthcare providers dealing with critical heart failure cases. Operating in the medical device market, the company employs a business model that includes the development, manufacturing, and sale of its specialized pumps. Revenue is generated through direct sales to healthcare institutions and partnerships with medical distributors.
At a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Tel Aviv-Yafo, Israel
- Employees
- 118
- Open positions
- 7
- Dealroom signal
- 54.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Cardiology and cardiovascular, Surgical Equipment, Tech for Hospitals and Clinics, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jul 2024 | $105M | $420M | NEA · OrbiMed · Viking Global Investors · JVC Investment Partners | ↗ |
| LATE VCOther financing | May 2023 | $55M | $220M | Pitango Venture Capital · NEA · ALIVE Israel HealthTech Fund · OrbiMed | ↗ |
Growth signals
Latest recorded traffic for Magenta Medical is 3.2K monthly website visits, up 332.4% over the last three months. Magenta Medical's team grew 11.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A3 investors entered at this stage
Abiomed
ABIOMED, LTD.
Jacques R. Seguin
Series B and later7 investors entered at this stage
NEA
ALIVE Israel HealthTech Fund
OrbiMed
Novo Holdings
Viking Global Investors- JPJVC Investment Partners
RA Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Magenta Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Magenta Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.